Abstract
Purpose
To evaluate the clinical and echocardiographic effects of prolonged cessation and resumption of left ventricular pacing among patients with chronic cardiac resynchronization therapy (CRT).
Methods
This was a retrospective analysis of patients with long-term CRT who had loss of left ventricular pacing because of battery depletion. Clinical assessment and echocardiographic data were analyzed with comparisons between implant, chronic CRT, loss of CRT, and after resumption of CRT.
Results
There were 7 CRT responders who underwent 8 successful pulse generator replacements due to loss of CRT 6.3 ± 2.3 months after reaching elective replacement interval. With initial CRT implantation, QRS duration decreased from 171 ± 25 to 145 ± 28 ms (P < 0.001) and left ventricular ejection fraction increased from 27.6 ± 8.1 to 53.9 ± 9.6% (P < 0.001). At pulse generator replacement, worsening heart failure was present 6 of 7 patients with significant deterioration of left ventricular function and the left ventricular ejection fraction decreased to 43.4 ± 8.4%(P = 0.001). After resumption of CRT, clinical status and cardiac function recovered with left ventricular ejection fraction increasing to 53.7 ± 8.7% (P = 0.001).
Conclusions
Prolonged loss of CRT is associated with significant deterioration of left ventricular function and functional status that is fully reversible with resumption of left ventricular pacing.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–80.
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–53.
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, de Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–50.
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.
Linde C, Abraham WT, Gold MR, St. John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834–43.
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–38.
Daubert JC, Saxon L, Adamson PB, Auricchio A, Berger RD, Beshai JF, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm. 2012;9(9):1524–76.
Manne M, Rickard J, Varma N, Chung MK, Tchou P. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival. Pacing Clin Electrophysiol. 2013;36(8):970–7.
Auricchio A, Stellbrink C, Block M, Sack S, Vogt J̈, Bakker P, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation. 1999;99(23):2993–3001.
Castellant P, Orhan E, Bertault-Valls V, Fatemi M, Etienne Y, Blanc JJ. Is “hyper response” to cardiac resynchronization therapy in patients with nonischemic cardiomyopathy a recovery, a remission, or a control? Ann Noninvasive Electrocardiol. 2010;15(4):321–7.
Cay S, Ozeke O, Ozcan F, Aras D, Topaloglu S. Mid-term clinical and echocardiographic evaluation of super responders with and without pacing: the preliminary results of a prospective, randomized, single-centre study. Europace. 2016;18(6):842–50.
Merlo M, Pyxaras SA, Pinamonti B, Barbati G, di Lenarda A, Sinagra G. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011;57(13):1468–76.
Landolina M, Curnis A, Morani G, Vado A, Ammendola E, D'onofrio A, et al. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer. Europace. 2015;17(8):1251–8.
Boriani G, Ritter P, Biffi M, Ziacchi M, Diemberger I, Martignani C, et al. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database. Europace. 2016;18(9):1366–73.
Zanon F, Martiqnani C, Ammendola E, Menardi E, Narducci ML, DE Filippo P, et al. Device longevity in a contemporary cohort of ICD/CRT-D patients undergoing device replacement. J Cardiovasc Electrophysiol. 2016;27(7):840–5.
Author information
Authors and Affiliations
Contributions
Hong-xia Niu—design and drafting article
Yi-ran Hu, Min Gu, and Jing Wang—data collection and data analysis
Wei Hua and Michael R. Gold—critical revision of article
Shu Zhang—approval of article
Corresponding authors
Ethics declarations
Conflict of interest
MR Gold—Consultant to Boston Scientific, Medtronic and EBR. Clinical trials with Boston Scientific and Medtronic
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Niu, Hx., Hu, Yr., Hua, W. et al. Plasticity of left ventricular function with cardiac resynchronization therapy. J Interv Card Electrophysiol 57, 289–294 (2020). https://doi.org/10.1007/s10840-019-00562-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-019-00562-7